Topical Chinese Patent Medicine For Knee Osteoarthritis Pain
W. Chen,J. Sun,Y. Zhao,M. Song,Z. Xue,Q. Chen,R. Zhu,Y. Jia,C. Wang
DOI: https://doi.org/10.1016/J.JOCA.2021.02.350
IF: 7.507
2021-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: Topical non-steroidal anti-inflammatory drugs (NSAIDs) are currently strongly recommended for individuals with osteoarthritis (OA), according to 2019 American College of Rheumatology Guideline. However, topical Chinese Patent Medicine (CPM), which has been widely used to improve clinical symptoms for OA in eastern countries is less defined. A comprehensive review of the literature is an important step for understanding its benefits for OA. We systematically reviewed the literature on the clinical efficacy of topical CPM in patients with knee OA to inform clinical practice. Methods: We performed a comprehensive search on PubMed, Cochrane Library, EMBASE and four universal Chinese databases (Biomedical Databases, National Knowledge Infrastructure, Wanfang, and Chongqing VIP) and reference lists of published articles through July 2020. Knee OA was confirmed by the American College of Rheumatology criteria or the Chinese orthopedic association criteria in all studies. We included only randomized controlled trials (RCTs) using topical CPM as the first-line treatment in adults with knee OA. To determine the effect of topical CPM on clinical symptoms, we extracted the Visual Analogue Scale (VAS, range 0-10) and the Western Ontario and McMaster Universities Arthritis Index pain scores (WOMAC pain, range 0-20), where a lower score indicates a better outcome. We also accepted the composite outcome criteria developed by the Chinese National Institute of Rheumatology as an endpoint (total effectiveness rate, range 0-100%, higher score = better outcome), which assesses the overall pain, physical function and wellness. Study quality was assessed in RevMan5.3 software using the Cochrane Risk of Bias Tool. The differences between treatment groups were reported as mean change (P-value). Results: We identified 541 potentially relevant studies. Twenty with a total of 2395 subjects (60% female, mean age = 59 years, mean pain duration = 6 years) met eligibility criteria. Table 1 summarized the included RCTs of analgesic topical CPM on pain and function measures (VAS, WOMAC scale and Total Effectiveness Rate). All studies were conducted in China and published between 2010 and 2020. The mean treatment duration was 13 days (range 5-60 days). For the treatment groups, six topical CPM were prescribed as the first-line treatment for pain treatment based on the syndrome differentiation, and administration for once/2 days to three times a day for 5 days-8 weeks. The control group treatments included oral NSAIDs (10 studies), topical NSAIDs (7 studies), sodium hyaluronate (1 study), off-loading brace (1 study) and hot compress (1 study). Overall quality of trials was modest. Nine studies showed significantly improved VAS pain scores compared to control groups (Mean Difference [MD] = 0.74; 95% confidence interval, 0.60 to 0.88; p<0.01). Two studies showed significantly improved WOMAC pain scores compared to control (p=0.02). Seven studies reported a significant improvement in overall clinical symptoms on both pain and function (p<0.01). Minor adverse events (rash, pruritus, swelling and anaphylases) were reported in the both treatment groups. Conclusions: This study suggested that Chinese topical CPM is safe and has potential benefits in knee pain relief compared to standard medications. Further rigorously designed studies are warranted to understand the analgesic effect, anti-inflammatory effect and the activation of blood circulation indicated in Chinese medicine for patients with knee OA. This study has been registered on PROSPERO (CRD42020172795).Dr. Weiheng Chen is supported by the China Association of Traditional Chinese Medicine (SATCM-2015-BZ402).Dr. Chenchen Wang is supported by the National Institutes of Health (K24AT007323) and in part supported by the Rheumatology Research Foundation Innovative Research Award.Table 1Twenty RCTs of Topical Chinese Patent Medicine for Knee Osteoarthritis PainAuthor, yearNaAgebTopical CPM (Formula, Dose)cControl InterventionDuration (wks)Outcome MeasuresEffect on Symptom(Mean or Percentage Improvement)dP valueZhao, 20086064Fufang Nanxing Zhitong plaster, once/2 days, for 24 hours at a time, 6 timesVoltaren emulsion, 3 times/day, 12 days2WOMAC pain1.33 ↓< 0.05Yu,200912053Xiaotongtie plaster, once/day,24 hours at a time, 8 wksCelecoxib tablets, 100 mg, twice/day, 8 wks8WOMAC Pain0.59 ↓< 0.01Hu, 20116062Xiaotongtie plaster, once/day, 24 hours at a time, 2 wksCelecoxib capsules, 200 mg, once/day, 2 wks2Chinese composite outcomeTreatment effect: ↑90% vs. 86.6%> 0.05Xu, 2011100NRXiaotongtie plaster, once/day, 24 hours at a time, 1 wkMeloxicam tablets, 7.5 mg, twice/day, 1wk1VAS pain0.46 ↓< 0.05Guo, 201118059Xiaotongtie plaster, once/day, 24 hours at a time, 15 daysDiclofenac tablets,75 mg, twice/day, 15 days2Chinese composite outcomeTreatment effect: ↑91.9% vs. 78.0%< 0.05Wang, 20118053Xiaotongtie plaster, once/day, 6 hours at a time, 1 wkDielofenac tablets, 25 mg, twice/day, 1 wk1VAS pain1.35 ↓< 0.01Zhang, 20116055Xiaotongtie plaster, once/day, 24 hours at a time, 4 wksDiclofenac tablets, 75 mg, 1-2 times/day, 4 wks4Chinese composite outcomeTreatment effect: ↑93% vs.56%< 0.01Lv,201116060Xiaotongtie plaster, once/day, 24 hours at a time, 5 timesDiclofenac tablets, 100 mg, once/day, 5 days1VAS pain1.5 ↓< 0.01Lu, 20116265Xiaotongtie plaster, once/day, 24 hours at a time, 7 daysDiclofenac tablets, 25 mg, 3 times/day, 7 days1Chinese composite outcomeTreatment effect: ↑86.67% vs. 84.38%> 0.05Xin, 201120065Xiaotongtie plaster, once/day, 24 hours at a time, 5 timesIndometacin cuptalam plaster, once/day, for 24 hours at a time, 5 times1Chinese composite outcomeTreatment effect: ↑92% vs. 84%< 0.05Author, yearNaAgebTopical CPM (Formula, Dose)cControl InterventionDuration (wks)Outcome MeasuresEffect on Symptom(Mean or Percentage Improvement)dP valueLi, 20116059Xiaotongtie plaster, once/day, 24 hours at a time, 5 daysVoltaren emulsion, 4 times/day, 5 days1VAS pain1.82 ↓< 0.05Wang 20115141Xiaotongtie plaster, once/day, 12-24 hours at a time, 1 wkVoltaren emulsion, 2-4times/day, 1 wk1Chinese composite outcomeTreatment effect: ↑100% vs. 79.2%< 0.01Shen, 201210053Fufang Nanxing Zhitong plaster, once/2 days, for 24 hours at a time, 1 wkLocal hot compress, 15 min, 3 times/day, 1 wk1VAS pain1.45 ↓< 0.05Song, 201210853Fufang Nanxing Zhitong plaster, once/2 days, for 24 hours at a time, 6timesVoltaren emulsion, 3 times/day, 12 days2Chinese composite outcomeTreatment effect: ↑91.07% vs. 73.08%< 0.05Li, 20135060Fufang Nanxing Zhitong plaster, once/day, for 8-12 hours at a time, 24 timesSodium hyaluronate, once/5 days, 5 times3VAS pain0.08 ↓> 0.05Ju, 201310358Shang Shan Hu plaster, once/day, for 24 hours at a timeDiclofenac tablets, 25-50 mg, 3 times/day2VAS pain0.36 ↓< 0.05Li, 201516064Zhentong Huoluo tincture, 10-15 min, 3 times/day, 20 daysVoltaren emulsion, 3 times/day, 7 days3Chinese composite outcomeTreatment effect: ↑96.25% vs. 66.25%< 0.01Chen, 20167258Tongluo Qutong plaster, once/day, for no more than 12 hours at a time, 10 daysDiclofenac ointment, 3-4 times/day, 10 days1VAS pain1.24 ↓< 0.05Qin, 201610559Tongluo Qutong plaster, once/day, for no more than 12 hours at a time, 30 daysCelecoxib tablets, 100 mg, twice/day, 30 days4Chinese composite outcomeTreatment effect: ↑92.73 vs. 72.00< 0.05Zhang, 20177657Gu Tong plaster, once/day, for no more than 12 hours at a time, 3 wksOff -Loading brace, twice/day, for 2 hours at a time, 3 wks3VAS pain1.67 ↑> 0.05a N= number of patients included; b Age reported in years as a mean; C Various ingredients in topical CPM with the Chinese herbs have the analgesic effects. d Between group comparisons. Analgesic effects: Aconite Root, Radix Angelicae dahuricae, Pricklyash Peel, Kadsura Pepper Stem,Manchurian Wildginger. Anti-inflammatory and healing effects: Doubleteeth Pubescent Angilica Root, Safflower, Chinese Angelica, Szechuan Lovage Rhizome. Six topical CPM included Fufang Nanxing Zhitong plaster, Xiaotongtie plaster, Shang Shan Hu plaster, Tongluo Qutong plaster, Gu Tong plaster and Zhentong Huoluo tincture. Open table in a new tab a N= number of patients included; b Age reported in years as a mean; C Various ingredients in topical CPM with the Chinese herbs have the analgesic effects. d Between group comparisons. Analgesic effects: Aconite Root, Radix Angelicae dahuricae, Pricklyash Peel, Kadsura Pepper Stem,Manchurian Wildginger. Anti-inflammatory and healing effects: Doubleteeth Pubescent Angilica Root, Safflower, Chinese Angelica, Szechuan Lovage Rhizome. Six topical CPM included Fufang Nanxing Zhitong plaster, Xiaotongtie plaster, Shang Shan Hu plaster, Tongluo Qutong plaster, Gu Tong plaster and Zhentong Huoluo tincture.